Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Indegene has scheduled investor and analyst meetings from May 26 to May 29, 2026. These include a virtual meeting with Sundaram Mutual Fund and participation in the 360 ONE Capital Annual Investor Conference in Mumbai. The company clarified no unpublished price sensitive information will be shared.
May 20 2026 19:05:00
Indegene Limited
Indegene hosted its Q4 & Annual FY26 earnings concall, highlighting record revenues and strategic achievements. The company reported Q4 FY26 revenue exceeding Rs.1,000 cr and full year revenue over Rs.3,500 cr, with 23.6% YoY growth. Management expressed confidence in FY27 driven by GenAI-led solutions and a strong pipeline.
May 06 2026 19:05:00
Indegene Limited
Indegene Ltd received an income tax demand of Rs. 43.69 crore for Assessment Year 2023-24 (Financial Year 2022-23) from the Income Tax Department. This demand is due to transfer pricing adjustments, and the company intends to contest it through MAP and domestic appellate remedies, expecting no material adverse impact.
May 05 2026 22:05:00
Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Indegene was identified as a Leader in the ISG Provider Lens™ 2026 report for Life Sciences Digital Services in Commercial Operations. This recognition for the third consecutive year highlights the company's strong domain expertise and use of AI/GenAI.
May 04 2026 17:05:00
Indegene Limited
Indegene Limited has been recognized as a Leader in the ISG Provider Lens report for Life Sciences Digital Services in Commercial Operations. This recognition highlights the company's strong domain expertise, proprietary technology platforms, and growing use of AI and GenAI.
May 04 2026 17:05:00
Indegene Limited
Indegene Limited has been recognized as a Leader in the ISG Provider Lens report for Life Sciences Digital Services in Commercial Operations. This recognition highlights the company's strong domain expertise, proprietary technology platforms, and growing use of AI and GenAI.
May 04 2026 17:05:00
Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Indegene announced the audio recording of its Q4 and Annual FY26 earnings call, held on April 30, 2026, is available. This provides investors access to the post-results discussion and management commentary.
Apr 30 2026 11:04:00
Indegene Limited
Indegene Limited submitted its Q4 FY26 Monitoring Agency Report on IPO proceeds utilization to SEBI. The report noted deviations in fund allocation from the original offer document, which were subsequently approved by shareholders. Approximately Rs.17.26 crore from the IPO proceeds remains unutilized.
Apr 29 2026 21:04:00
Indegene Limited
INDEGENE LIMITED board approved a final dividend of Rs. 112.5 per equity share. The record date for this dividend will be announced subsequently.
Apr 29 2026 20:04:00
Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Indegene announced strong Q4 FY26 and full-year FY26 results, with Q4 revenue rising 32.8% YoY to Rs.1,003.4 crore and full-year revenue reaching Rs.3,510.5 crore. The board also recommended a final dividend of Rs.2.25 per share for FY26, reflecting robust financial performance and operating fundamentals.
Apr 29 2026 20:04:00
Read More